[MOL] Superb Stock Pick [01190] Medicine On Line

[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

[MOL] Superb Stock Pick


Global Seafood Technologies just became fully reporting and newly listed on the NASDAQ Over -The-Counter Bulletin Board. The company, who's revenues increased over 500% from 1995 to 2000, just completed two years of investment into two new markets: aquaculture and their premium salt water bait line "Killer Bee Bait" and are poised to reap their benefits. While these investments stymied profit growth until recently, the billion dollar bait market has responded enthusiastically to GSFT's new line. Over 500 outlets now carry the product line including Wal*Mart, K-Mart, Boaters World and many others. Sales of the Killer Bee Bait have increased 220% in the first six months of this year, over a comparable period last year !

The company's aquaculture line may prove to be the pearl in the GSFT portfolio as the growth of fresh water shrimp is expected to be a multi-billion dollar market worldwide. U.S. based aquaculture of fresh water shrimp has many advantages- including shipping costs, virus resistance,  fast growth rates- and is expected to take a significant market share of the $2.5 billion dollar domestic shrimp market in the next five years. Golbal Seafood Technologies will be turning their first commercial production, revenue producing run this quarter. The company also has a strong aquaculture expansion plan in place based on early results.

Because earnings lagged as the company invested heavily in these new areas over the past couple of years, the stock is trading at an extremely low multiple. We rate it as a strong buy and anticipate it to return to it's 1999 level of $2.50 a share over the next 6 to 12 months.


Safe Harbor Statement

Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for forward-looking statements. Except for historical information contained herein, the matters discussed are forward-looking statements that involve risks and uncertainties. When used herein, words such as "anticipate", "believe", "estimate", "expect" and "intend" and similar expressions, as they relate to 
the Company or its management,  identify forward-looking statements.
 Such forward-looking statements are based on the beliefs of the Company’s management, as well as assumptions made by and information currently available to the Company’s management. Among the factors that could cause actual results to differ materially are the following: the effect of business and economic conditions; the impact of competitive products and pricing; capacity and supply constraints or difficulties; product development, commercialization or technological difficulties; the regulatory and trade environment; and the risk factors reported from time to time in the Company’s  
SEC reports. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. The Company undertakes no obligation to update any  forward-looking statements as a result of future events or developments. 

All material herein was prepared by Online Investments based upon information supplied by the company or other sources believed to be reliable. The information contained herein is not guaranteed by Online Investments to be accurate, and should not be considered to be all-inclusive. This material is for informational purposes only and should 
not be construed as an offer or solicitation of an offer to buy or sell 
securities. Online Investments is not a licensed broker, broker dealer, market marker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities. 

This is an automatically-generated notice.  If you'd like to be removed
from the mailing list, please visit the Medicine-On-Line Discussion Forum
at <http://www.meds.com/con_faq.html>, or send an email message to:
with the subject line blank and the body of the message containing the line:
unsubscribe mol-cancer your-email-address
where the phrase your-email-address is replaced with your actual email